---
schema_version: "secwatch.filing_event.v1"
accession: "0000896264-26-000014"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2026-02-18T23:59:59+00:00"
generated_at: "2026-05-16T02:17:20.819289+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# USANA Q4 net loss $1.8M; core customers down 15%; FY2026 guidance flat to 8% growth

## Summary
- Q4 net loss $1.8M vs profit $4.5M YoY; adjusted diluted EPS $0.60 (down 6% from $0.64).
- FY2025 net sales $925M (+8% YoY); core nutritional net sales down 8%, active customers down 15% to 387k.
- Recorded $7M goodwill impairment and $6.5M cost realignment charge in Q4, boosting effective tax rate to 72.4%.
- FY2026 guidance: consolidated net sales $925M-$1.0B (flat to 8% growth); adjusted diluted EPS $1.95-$2.29.
- Hiya net sales grew 17% in FY2025; Rise Wellness net sales tripled; non-core now 16% of consolidated sales.

## SEC filing metadata
- accession: 0000896264-26-000014
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2026-02-18T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000089626426000014/0000896264-26-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000089626426000014/usna-20260217.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000896264-26-000014
- JSON: https://secwatch.observer/filing/0000896264-26-000014.json
- Plain text: https://secwatch.observer/filing/0000896264-26-000014.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.